Checkpoint Inhibition in Stage III NSCLC: Current Practice, Open Questions, and Future Directions

Download the slidesets and watch an on-demand, CME-certified Webcast from our satellite symposium at SITC 2018 where expert faculty shared their perspectives on the use of checkpoint inhibitors in the treatment of unresectable stage III NSCLC, including review of the latest clinical data and case discussions on the subtleties and challenges of their optimal application in this earlier disease setting.
Julie Brahmer, MD, MSc
Edward B. Garon, MD, MS
Naiyer Rizvi, MD

Downloadable Slidesets

Download this slideset to review historical data for concurrent CRT compared to the latest clinical evidence for checkpoint inhibitor therapy in the care of patients with unresectable stage III NSCLC.

Edward B. Garon, MD, MS Released: November 8, 2018

Download this slideset to see how our expert faculty would apply checkpoint inhibitor therapy in the treatment of a series of case patients with unresectable stage III NSCLC, including a frail patient, a patient with delayed recovery following concurrent CRT, and a patient with an actionable mutation.

Julie Brahmer, MD, MSc Released: November 8, 2018

Download this slideset to get up to date on clinical research being done to improve checkpoint inhibitor therapy for unresectable stage III NSCLC and to move it into resectable early-stage disease.

Naiyer Rizvi, MD Released: November 8, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?